Top Line

Pfizer is expected to ask the Food and Drug Administration to authorize its COVID-19 vaccine booster shot for Americans between the ages of 16 and 17. News shops informed of Monday, as public health experts track down the new Omicron version of the coronavirus.

important facts

- Advertisement -

Unknown sources said Pfizer plans to ask the FDA for authorization this week. Washington Post And this new York Times,

Pfizer has not yet announced the request, and did not immediately respond. CNN Or Businesshala’ Comment request.

The report comes less than two weeks after the FDA Updates Its emergency use authorizations for Pfizer and Moderna’s COVID-19 vaccines make all adults eligible for a booster six months after getting their initial shots.

Pfizer’s initial dose of vaccine was Authorized Last month for 5-11 year olds.

pfizer is the only vaccine Available For those under the age of 18 in the US.

- Advertisement -